Please select the option that best describes you:

What is your preferred graft source and conditioning regimen in a patient with Fanconi anemia and AML undergoing stem cell transplant?  

Is there a role for non-myeloablative regimens?



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more